Stay updated with breaking news from Wacker Biosolutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wacker Chemie (ETR:WCH – Get Rating) received a €190.00 ($208.79) price objective from equities researchers at Baader Bank in a note issued to investors on Monday, Borsen Zeitung reports. Baader Bank’s target price would suggest a potential upside of 23.82% from the stock’s current price. Other equities analysts also recently issued research reports about the […]
The long-term partnership is aimed to make fermentation-based biotin available for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative.
Biosyntia and Wacker intend to produce fermentation-based biotin and make it broadly available in the market. Wacker is expanding its range of fermentation-based ingredients in the food and nutraceutical sector. Production of biotin at Wacker is to take place in Europe. Biotin, also known as vitamin B7, is a coenzyme for the metabolism of proteins, fats, and carbohydrates.
Danish biotech company, Biosyntia, and Munich-based, Wacker Group, are planning to expand production of fermentation-based biotin across Europe and into new markets.
Danish biotech company, Biosyntia, and Munich-based, Wacker Group, are planning to expand production of fermentation-based biotin across Europe and into new markets.